Biotech/pharma M&A activity definitely heating up. There is also renewed interest in neuroscience after the approval of Leqembi and other transactions. It's a massive area of unmet need.
Bristol Myers to acquire Karuna for $14Billion, page-22
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.68 |
Change
0.370(1.92%) |
Mkt cap ! $2.536B | |||
| Open | High | Low | Value | Volume |
| $19.39 | $19.98 | $19.38 | $4.233M | 214.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 138 | $19.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.69 | 66 | 3 |
View Market Depth
| Last trade - 13.07pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.71 |
Change
0.370 ( 1.65 %) |
||||
| Open | High | Low | Volume | ||
| $19.41 | $19.97 | $19.39 | 38655 | ||
| Last updated 13.27pm 14/06/2024 ? | |||||
| NEU (ASX) Chart |